Zoetis Inc.
ZTSLast close · Oct 16, 202679.32+0.90 (+1.15%)
Market cap$32.8B
5 firms' latest targets, last 90 days: median $85.00 ($74.00–$94.00), 7% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-16 | Goldman Sachs | $74.00 | — | -7% |
| 2026-08-25 | Cantor Fitzgerald | $94.00 | — | +19% |
| 2026-08-20 | Stifel | $80.00 | ▼ 6% | +1% |
| 2026-08-07 | Morgan Stanley | $85.00 | ▼ 14% | +7% |
| 2026-07-27 | UBS | $85.00 | ▼ 14% | +7% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $8.5B | +6% | $5.07 | +13% | est. $8.5B+0% | est. $5.41 | 9 |
| 2024reported | $9.3B | +8% | $5.47 | +8% | est. $9.2B+0% | est. $5.89 | 12 |
| 2025reported | $9.5B | +2% | $6.02 | +10% | est. $9.4B+0% | est. $6.34 | 13 |
| 2026 | $9.3B | -2% | $6.21 | -2% | $9.1B–$9.4B | $5.72–$6.31 | 11 |
| 2027 | $9.4B | +2% | $6.41 | +3% | $8.9B–$9.8B | $6.04–$6.83 | 12 |
| 2028 | $9.8B | +4% | $6.92 | +8% | $9.0B–$11.0B | $5.64–$8.10 | 13 |
| 2029 | $10.3B | +5% | $8.12 | +17% | $9.8B–$10.9B | $7.66–$8.76 | 11 |
| 2030 | $10.9B | +5% | $9.06 | +12% | $10.4B–$11.5B | $8.55–$9.77 | 6 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.